GSA Capital Partners’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,022
Closed -$9K – 1865
2026
Q2
$9K Buy
+10,022
New +$9.9K ﹤0.01% 1691

Other funds holding BFRI

GSA Capital Partners's BFRI Position: Q3 2026 in Review

GSA Capital Partners sold out of Biofrontera (BFRI) in Q3 2026, closing a stake of 10,022 shares — an estimated $9K sold.

GSA Capital Partners first reported a position in BFRI in Q2 2026 and held it in 1 quarter. The position peaked at $9K in Q2 2026. 20 funds tracked by Wall St. Rank hold BFRI as of Q3 2026.

  • GSA Capital Partners reported no remaining Biofrontera position as of Q3 2026 after selling out during the quarter.
  • GSA Capital Partners sold 10,022 Biofrontera shares in Q3 2026, an estimated $9K.
  • GSA Capital Partners first reported a position in Biofrontera in Q2 2026 and held it in 1 quarter.
  • GSA Capital Partners's Biofrontera position peaked at $9K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Biofrontera as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.